Squalene attenuates doxorubicin resistance in hepatocellular carcinoma by targeting SIRT6 to inhibit ERK1 deacetylation. - Xiao G; Liu F; Wang Q; He B; Fu Y (Molecular and cellular biochemistry, 2026)